课题基金 / 基金详情

Inflammatory Caspases in Innate Immunity and Inflammation

Inflammatory Caspases in Innate Immunity and Inflammation
先天免疫和炎症中的炎症性半胱天冬酶
批准号:
9127673
负责人:
Thirumala-Devi Kanneganti
金额:
$44.88万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-05-01 至 2022-04-30

项目摘要

项目成果

Thirumala-Devi Kanneganti的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): Aspergillus fumigatus (A. fumigatus) is an important human fungal pathogen, which is responsible for significant morbidity and mortality amongst immunocompromised patients. In recent years, we have made important progress in understanding the molecular mechanisms that regulate sensing of pathogens by pattern-recognition receptors (PRRs), including Toll-like receptors (TLRs), NOD-like receptors (NLRs), AIM2-like receptors (ALRs) and RIG-I like receptors (RLRs). Certain members of the NLR and ALR family assemble a cytoplasmic multi-protein complex termed the 'inflammasome', which activates caspase-1 and induces maturation and secretion of the pro-inflammatory cytokines IL-1β and IL-18. Our recent study demonstrated that intracellular sensing of A. fumigatus requires a coordinated effort between the NLRP3 and AIM2 inflammasomes. However, the molecular mechanisms and signaling pathways leading to activation of these protective responses are completely unknown. In this grant application for renewal, we propose to investigate the signaling pathways regulating activation of inflammasomes driven by A. fumigatus infection. Completion of this proposal is expected to identify the major innate immune sensors that are directly sensing A. fumigatus and unravel the molecular mechanisms that regulate formation of inflammasomes in response to A. fumigatus. These discoveries are expected to identify novel signaling pathways that could be targeted by therapeutic interventions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of lung inflammatory and antiviral responses during coronavirus infection
Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases
Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases
Targeting innate immune pathways, and inflammatory cell death in cytokine-mediated diseases